Chemotherapy Treatment Market Research Report 2024-2030: Advancements in Targeted Chemotherapy and Personalized Treatment Plan Developments Driving Growth [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
Billion by 2030 with a CAGR of a 2.2%. The Plant Derivatives Drug Class segment is also set to grow at 1.7% CAGR over the analysis period. Gain insights into the U.S. market, which was estimated at $7.7 Billion in 2023, and China, forecasted to grow at an impressive 3.6% CAGR to reach $6.0 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Chemotherapy Treatment Market Chemotherapy Treatment Market Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Chemotherapy Treatment was estimated at US$28.2 Billion in 2023 and is projected to reach US$31.5 Billion by 2030, growing at a CAGR of 1.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Several key trends are drivi
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- AbbVie (ABBV) Rises Yet Lags Behind Market: Some Facts Worth Knowing [Yahoo! Finance]Yahoo! Finance
- Glaucoma Surgical Devices Market to Hit Valuation of US$ 1,546 Million by 2033 | Astute Analytica [Yahoo! Finance]Yahoo! Finance
- AbbVie (ABBV) Benefitted from Top-Line Growth From Its Immunosuppressive Drugs [Yahoo! Finance]Yahoo! Finance
- Is AbbVie Stock a Buy? [Yahoo! Finance]Yahoo! Finance
- Is AbbVie Inc. (ABBV) the Best Dividend Stock for Steady Income? [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 10/30/24 - Beat
ABBV
Sec Filings
- 12/18/24 - Form 4
- 12/16/24 - Form 144
- 12/13/24 - Form 8-K
- ABBV's page on the SEC website